Salarius Pharmaceuticals, Inc. logo

Salarius Pharmaceuticals, Inc. (DCOY)

Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
5. 88
-0.22
-3.6066%
$
3.32M Market Cap
- P/E Ratio
- Div Yield
4,325 Volume
- Eps
$ 6.1
Previous Close
Add Transaction
Day Range
5.5 6.31
Year Range
4.32 415.8
Want to track DCOY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Decoy Therapeutics Inc. (DCOY) Discusses Corporate Overview and Pipeline Progress in Antiviral Drug Development Transcript

Decoy Therapeutics Inc. (DCOY) Discusses Corporate Overview and Pipeline Progress in Antiviral Drug Development Transcript

Decoy Therapeutics Inc. (DCOY) Discusses Corporate Overview and Pipeline Progress in Antiviral Drug Development Transcript

Seekingalpha | 2 months ago
ProMetic Life Sciences (OTCMKTS:PFSCF) vs. Decoy Therapeutics (NASDAQ:DCOY) Financial Analysis

ProMetic Life Sciences (OTCMKTS:PFSCF) vs. Decoy Therapeutics (NASDAQ:DCOY) Financial Analysis

ProMetic Life Sciences (OTCMKTS:PFSCF - Get Free Report) and Decoy Therapeutics (NASDAQ: DCOY - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk and dividends. Profitability This table compares ProMetic Life

Defenseworld | 3 months ago